MNOV
Price
$2.15
Change
-$0.01 (-0.46%)
Updated
Dec 20, 04:59 PM (EDT)
54 days until earnings call
VIR
Price
$7.34
Change
-$0.03 (-0.41%)
Updated
Dec 20 closing price
59 days until earnings call
Ad is loading...

MNOV vs VIR

Header iconMNOV vs VIR Comparison
Open Charts MNOV vs VIRBanner chart's image
Medicinova
Price$2.15
Change-$0.01 (-0.46%)
Volume$2.84K
CapitalizationN/A
Vir Biotechnology
Price$7.34
Change-$0.03 (-0.41%)
Volume$3.75M
CapitalizationN/A
MNOV vs VIR Comparison Chart
Loading...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNOV vs. VIR commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and VIR is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MNOV: $2.17 vs. VIR: $7.34)
Brand notoriety: MNOV and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNOV: 94% vs. VIR: 258%
Market capitalization -- MNOV: $105.45M vs. VIR: $1.01B
MNOV [@Biotechnology] is valued at $105.45M. VIR’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNOV’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MNOV’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MNOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNOV’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 3 bullish TA indicator(s).

  • MNOV’s TA Score: 4 bullish, 5 bearish.
  • VIR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MNOV is a better buy in the short-term than VIR.

Price Growth

MNOV (@Biotechnology) experienced а +3.33% price change this week, while VIR (@Biotechnology) price change was -1.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MNOV is expected to report earnings on Feb 14, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.01B) has a higher market cap than MNOV($105M). MNOV YTD gains are higher at: 44.667 vs. VIR (-27.038). MNOV has higher annual earnings (EBITDA): -11.96M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. MNOV (42.3M). MNOV has less debt than VIR: MNOV (202K) vs VIR (113M). VIR has higher revenues than MNOV: VIR (62M) vs MNOV (0).
MNOVVIRMNOV / VIR
Capitalization105M1.01B10%
EBITDA-11.96M-562.68M2%
Gain YTD44.667-27.038-165%
P/E RatioN/AN/A-
Revenue062M-
Total Cash42.3M914M5%
Total Debt202K113M0%
FUNDAMENTALS RATINGS
MNOV: Fundamental Ratings
MNOV
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNOVVIR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTXAX47.810.72
+1.53%
FullerThaler Behavioral Sm-Cp Gr A
NAWIX45.800.35
+0.77%
Voya Global High Dividend Low Vol I
BLADX9.370.03
+0.32%
BlackRock Managed Income Investor A
PRITX19.58N/A
N/A
T. Rowe Price International Stock
GTAPX13.33N/A
N/A
Glenmede Quant US Long/Short Equity

MNOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
+0.46%
FATE - MNOV
36%
Loosely correlated
+1.20%
MNKD - MNOV
30%
Poorly correlated
+8.73%
VIR - MNOV
29%
Poorly correlated
-0.41%
TIL - MNOV
28%
Poorly correlated
+2.64%
QLGN - MNOV
28%
Poorly correlated
-3.47%
More